Radiosynthesis and evaluation of N-(3-[18F]fluoropropyl)paroxetine as a radiotracer for in vivo labeling of serotonin uptake sites by PET

Bai, 1990, No-carrier-added (NCA) N-(3-[18F]fluoropropyl)-N-norbuprenorphine and N-(3-[18F]fluoropropyl)-N-nordiprenorphine—synthesis, anatomical distribution in mice and rats, and tomographic studies in a baboon, Nucl. Med. Biol., 17, 217 Battaglia, 1990, MDMA effects in brain: Pharmacologic profile and evidence of neurotoxicity from neurochemical and autoradiographic studies, 171 Battaglia, 1987, 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites, J. Pharmacol. Exp. Ther., 241, 911 Block, 1987, The N.C.A. nucleophilic 18F-fluorination of 1,N-disubstituted alkanes as fluoroalkylation agents, J. Labelled Compd. Radiopharm., 24, 1029, 10.1002/jlcr.2580240904 Block, 1988, 18F-Fluoroalkylation of H-acidic compounds, J. Labelled Compd. Radiopharm., 25, 201, 10.1002/jlcr.2580250211 Bowen, 1983, Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease, J. Neurochem., 41, 266, 10.1111/j.1471-4159.1983.tb11838.x Cash, 1985, High and low affinity [3H]imipramine binding sites in control and Parkinsonian brains, Eur. J. Pharmacol., 117, 71, 10.1016/0014-2999(85)90473-X Chesis, 1990, Synthesis and in vitro characterization of fluorinated U-50488 analogs for PET studies of kappa opioid receptors, Appl. Radiat. Isot., 41, 267, 10.1016/0883-2889(90)90190-R Chesis, 1990, N-(3-[18F]Fluoropropyl)-N-nordiprenorphine: synthesis and characterization of a new agent for imaging opioid receptors with positron emission tomography, J. Med. Chem., 33, 1482, 10.1021/jm00167a031 Chi, 1986, Synthesis of no-carrier-added N-([18F]fluoroalkyl)spiperone derivatives, Appl. Radiat. Isot., 37, 1173, 10.1016/0883-2889(86)90002-X Dannals, 1987, Synthesis of radiotracers for studying muscarinic cholinergic receptors in the living human brain using positron emission tomography: [11C]dexetimide and [11C]levetimide, Appl. Radial. Isot., 39, 291, 10.1016/0883-2889(88)90018-4 Dannals, 1989, Synthesis of a radiotracer for studying serotonin uptake sites: carbon-11 labeled N-methylparoxetine, J. Labelled Compd. Radiopharm., 26, 205, 10.1002/jlcr.2580260192 DeSouza, 1987, Autoradiographic localization of 3H-paroxetine labeled serotonin uptake sites in rat brain, Synapse, 1, 488, 10.1002/syn.890010513 Habert, 1985, Characterization of [3H]paroxetine binding to rat cortical membranes, Eur. J. Pharmacol., 118, 107, 10.1016/0014-2999(85)90668-5 Kiesewetter, 1986, Syntheses and D2 receptor affinities of derivatives of spiperone containing aliphatic halogens, Appl. Radial. Isot., 37, 1181, 10.1016/0883-2889(86)90003-1 Kiesewetter, 1990, Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands, Nucl. Med. Biol., 17, 347 Magnussen, 1982, Paroxetine, a potent selective long-acting inhibitor of synaptosomal 5 HT-uptake in mice, J. Neural. Transm., 55, 217, 10.1007/BF01276577 Marcusson, 1988, Characterization of [3H]paroxetine binding in rat brain, J. Neurochem., 50, 1783, 10.1111/j.1471-4159.1988.tb02479.x McPherson, 1985, Kinetic, EBDA, Ligand, Lowry Mellerup, 1983, High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes, Eur. J. Pharmacol., 96, 303, 10.1016/0014-2999(83)90321-7 Moerlein, 1989, No-carrier-added synthesis of N-ω-(F-18)fluoroethyl SCH-23390: a potential agent for mapping cerebral dopamine D-1 receptors, J. Nucl. Med., 30, 931 Palmer, 1987, Presynaptic serotonergic dysfunction in patients with Alzheimer's disease, J. Neurochem., 48, 8, 10.1111/j.1471-4159.1987.tb13120.x Satyamurthy, 1986, No-carrier-added 3-(2′-[18F]fluoroethyl)spiperone, a new dopamine receptorbinding tracer for positron emission tomography, Nucl. Med. Biol., 13, 617 Scheffel, 1989, In vivo labeling of serotonin uptake sites with [3H]paroxetine, J. Neurochem., 52, 1605, 10.1111/j.1471-4159.1989.tb09215.x Scheffel, 1990, Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomographic ligand?, Brain Res., 527, 89, 10.1016/0006-8993(90)91064-N Schleyer, 1990, Separation of [18F]fluoride from [18O]water using anion exchange resin, Appl. Radiat. Isotop., 41, 531, 10.1016/0883-2889(90)90034-E Shiue, 1987, No-carrier-added (NCA) (±)-N-(3-[18F]fluoropropyl)-N-normetazocine—Synthesis and PET studies in a baboon, Nucl. Med. Biol., 14, 119 Welch, 1988, N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor, Nucl. Med. Biol., 15, 83 Wolfe, 1987, Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine, J. Pharmacol. Exp. Ther., 241, 196